Puma Biotechnology, Inc. (PBYI)
6.67
-0.21
(-3.05%)
USD |
NASDAQ |
Feb 10, 15:40
Puma Biotechnology Total Liabilities (Quarterly) : 87.59M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nephros, Inc. | 3.241M |
| Pfizer Inc. | -- |
| Rigel Pharmaceuticals, Inc. | 124.92M |
| Vanda Pharmaceuticals, Inc. | 135.14M |
| CorMedix, Inc. | 376.73M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 202.86M |
| Shareholders Equity (Quarterly) | 115.27M |
| Debt to Equity Ratio | 0.3561 |
| Current Ratio | 1.736 |
| Net Debt Paydown Yield | 4.30% |